Outlook Therapeutics Q1 Adj. EPS $(0.22) Misses $(0.18) Estimate, Sales $(1.208M) Miss $5.025M Estimate

Outlook Therapeutics, Inc. 0.00% Pre

Outlook Therapeutics, Inc.

OTLK

0.44

0.44

0.00%

+0.02% Pre
Outlook Therapeutics (NASDAQ: OTLK) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.18) by 22.22 percent. This is a 75.28 percent increase over losses of $(0.89) per share from the same period last year. The company reported quarterly sales of $(1.208 million) which missed the analyst consensus estimate of $5.025 million by 124.04 percent.
Every question you ask will be answered
Scan the QR code to contact us
whatsapp
Also you can contact us via